Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States

Background: Norepinephrine remains the first-line option to manage patients with circulatory shock. Limited evidence exists evaluating noncatecholamine compounds as first-line monotherapy for managing noncardiogenic shock. Objective: To compare vasopressin monotherapy with norepinephrine monotherapy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of pharmacotherapy 2020-03, Vol.54 (3), p.213-218
Hauptverfasser: Haan, Bradley J., Cadiz, Megan L., Natavio, Allycia M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!